NCT07850284Recruiting

SMS-Based Remote Symptom Monitoring for Patients With Plasma Cell Disorders

Mayo Clinic

Start Date

8/25/2026

Completion Date

8/25/2028

Summary

This study evaluates whether daily SMS-based (text messages) symptom monitoring is feasible and acceptable in patients who are undergoing treatment for multiple myeloma (MM) or systemic light chain amyloidosis (AL), and whether it can help in early identification of symptoms that may require clinical attention.

Eligibility Criteria

Age Range: 18 years to No maximum

Inclusion Criteria: * Age \>= 18 years * Diagnosis of MM or AL based on IMWG diagnostic criteria * Planned to start a new treatment within 14 days (+/-7 days) * Able to provide written informed consent Exclusion Criteria: * Not able to give informed consent

Interventions

OTHER

Non-Interventional Study

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

AL AmyloidosisMultiple Myeloma

Locations

Mayo Clinic in Rochester

Rochester, Minnesota 55905

United States

Run studies, or work at a research site?

Corterve helps sites and sponsors reach patients who are looking for trials. It does not determine eligibility and does not promise an enrolment outcome.

For sponsors, CROs and sites

What Corterve sells to organisations, and the anti-kickback constraints it works within.

Services and published prices

Coordinate outreach and marketing across multiple sites as one effort, plus study-site logistics and tech support.

For research sites

One published licence rate, the same for every site, and the fees a site is never charged.